Shares of WAVE Life Sciences were trading at $6.41 as of May 06. Over the last 52-week period, shares are up 14.67%. Given ...

WAVE Life Sciences Ltd (NASDAQ:WVE) is set to release its Q1 2025 earnings on May 8, 2025. The consensus estimate for Q1 2025 ...

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at ...

Also in March 2025, Wave announced that the company met with the U.S. Food and Drug Administration (FDA) on WVE-N531 to ...

Good morning and welcome to the Wave Life Sciences First Quarter 2025 Earnings Conference Call. [Operator Instructions] I'll now turn the call over to Kate Rausch, Vice President, Investor ...

CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to ...

May 08, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health ...

SINGAPORE (AP) — SINGAPORE (AP) — Wave Life Sciences Pte. Ltd. (WVE) on Thursday reported a loss of $46.9 million in its first quarter. On a per-share basis, the Singapore-based company said it had a ...

Wave Life Sciences Ltd. announced the completion of dosing in the first two cohorts of the INLIGHT trial for the obesity treatment WVE-007, with clinical data expected in the second half of 2025.

WAVE Life Sciences (NASDAQ:WVE) is gearing up to announce its quarterly earnings on Thursday, 2025-05-08. Here's a quick overview of what investors should know before the release. Analysts are ...